Pharma Mar | PHM - Equity Capital And Reserves


Pharma Mar reported EUR251.83M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 32.61M 8.98M Dec/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Almirall EUR 1.49B 24.03M Dec/2025
Avita Medical AUD -16.65M 3.76M Dec/2025
Dianthus Therapeutics USD 493.4M 53.05M Dec/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Moderna USD 8.65B 680M Dec/2025
Organon & Co USD 906M 173M Sep/2025
Pharma Mar EUR 251.83M 54.32M Dec/2025
Revvity USD 7.38B 180.27M Sep/2025
Tectonic Therapeutic USD 251.33M 16.2M Dec/2025
Viatris USD 15.22B 352.9M Sep/2025
Xeris Pharmaceuticals USD 13.69M 14.55M Dec/2025